Abstract:High purity alumina as well as zirconia ceramics have been widely used as orthopaedic implant biomaterials and dental devices displaying optimal, but sometimes exclusive, mechanical properties. In order to combine the advantages of alumina and zirconia ceramic materials different types of composites have been developed in which either zirconia is dispersed in an alumina matrix or vice versa. Orthopaedic and dental implant biomaterials are expected to be in contact with living tissues for a long period of time … Show more
“…In a previous study we reported a new ZTA ceramic obtained within a project aimed to develop new ceramic materials of high strength and toughness suitable for biomedical applications and demonstrated that it did not elicit mutagenic nor carcinogenic effects in vitro (7). The material is currently under consideration for patent and we proposed it as a suitable biomaterial for load bearing applications such as orthopaedic implants or dental devices.…”
The development of a new chromia-doped Zirconia Toughened Alumina (ZTA) material was previously reported as displaying mechanical properties suitable for implants with load bearing applications, such as orthopaedic and dental implants. This type of biomaterial is expected to be in contact with living tissues for a long period of time and its long-term toxicity must be carefully evaluated. In this study the suitability of this ZTA material as a candidate biomaterial for orthopaedic implants and dental devices was further investigated in vivo in comparison to alumina and zirconia, which are currently used in orthopaedic and dental surgery. Cylinders of the materials were implanted in vivo in white rabbits, and local and systemic tissue reactions were analyzed at different time intervals after surgery. Radiologic examinations displayed the absence of radiolucence around cylinders and no signs of implant loosening up to twelve months. No tumours developed in the animals either locally (at the site of implantation), or systemically in the peripheral organs. The results obtained suggest that this new ZTA material does not display any long term pathogenic effect in vivo. These findings extend our previous observations on the biocompatibility and the absence of any long-term carcinogenic effect in vitro ofthis material which displays interesting properties for biomedical applications. In conclusion, we report the in vivo characterization of a new chromia-doped ZTA material and confirm its suitability as a candidate biomaterial for orthopaedic implants and dental devices since it does not give any local nor systemic toxicity even after a long period of time after implantation.Alumina and/or zirconia-based ceramic materials generally display high wear resistance and are considered suitable for load bearing applications (1-2). In particular, these materials are indicated for applications in young patients, with possible long-term life expectancy both of the implants and the patients themselves (3). On this basis, long term possible effects of these materials, as well as acute toxicity, should be carefully evaluated when considering their biocompatibility. However, few papers in the literature deal with the biocompatibility of these materials especially in terms of long-
“…In a previous study we reported a new ZTA ceramic obtained within a project aimed to develop new ceramic materials of high strength and toughness suitable for biomedical applications and demonstrated that it did not elicit mutagenic nor carcinogenic effects in vitro (7). The material is currently under consideration for patent and we proposed it as a suitable biomaterial for load bearing applications such as orthopaedic implants or dental devices.…”
The development of a new chromia-doped Zirconia Toughened Alumina (ZTA) material was previously reported as displaying mechanical properties suitable for implants with load bearing applications, such as orthopaedic and dental implants. This type of biomaterial is expected to be in contact with living tissues for a long period of time and its long-term toxicity must be carefully evaluated. In this study the suitability of this ZTA material as a candidate biomaterial for orthopaedic implants and dental devices was further investigated in vivo in comparison to alumina and zirconia, which are currently used in orthopaedic and dental surgery. Cylinders of the materials were implanted in vivo in white rabbits, and local and systemic tissue reactions were analyzed at different time intervals after surgery. Radiologic examinations displayed the absence of radiolucence around cylinders and no signs of implant loosening up to twelve months. No tumours developed in the animals either locally (at the site of implantation), or systemically in the peripheral organs. The results obtained suggest that this new ZTA material does not display any long term pathogenic effect in vivo. These findings extend our previous observations on the biocompatibility and the absence of any long-term carcinogenic effect in vitro ofthis material which displays interesting properties for biomedical applications. In conclusion, we report the in vivo characterization of a new chromia-doped ZTA material and confirm its suitability as a candidate biomaterial for orthopaedic implants and dental devices since it does not give any local nor systemic toxicity even after a long period of time after implantation.Alumina and/or zirconia-based ceramic materials generally display high wear resistance and are considered suitable for load bearing applications (1-2). In particular, these materials are indicated for applications in young patients, with possible long-term life expectancy both of the implants and the patients themselves (3). On this basis, long term possible effects of these materials, as well as acute toxicity, should be carefully evaluated when considering their biocompatibility. However, few papers in the literature deal with the biocompatibility of these materials especially in terms of long-
“…Additives such as zirconia are incorporated into alumina matrices to serve as toughening agents. The details of these mechanisms are beyond the scope of this review, but in short, controlled phase transformation of sub-micron zirconia particles within the alumina matrix prevents subcritical crack propagation, resulting in decreased fracture rates (De Aza et al, 2002;Insley et al, 2002;Maccauro et al, 2009). However, these materials have a relatively short clinical history, so further monitoring is necessary.…”
“…These biocompatibility capabilities are preserved also on binary zirconia-alumina composites, as assessed by Maccauro et al [49]. Their results, based on DNA damage, mutagenicity, and cancerogenetic potential in mammalian cells, confirmed that ZTA material could be considered suitable for biomedical applications.…”
Dental implant biomaterials are expected to be in contact with living tissues, therefore their toxicity and osseointegration ability must be carefully assessed. In the current study, the wettability, cytotoxicity, and genotoxicity of different alumina-zirconia-titania composites were evaluated. The surface wettability determines the biological event cascade in the bioceramic/human living tissues interface. The measured water contact angle indicated that the wettability strongly depends on the ceramic composition. Notwithstanding the contact angle variability, the ceramic surfaces are hydrophilic. The cytotoxicity of human gingival fibroblast cells with materials, evaluated by an (3-(4,5 methylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) test, revealed an absence of any cytotoxic effect. A relationship was found between the cell viability and the wettability. It was subsequently deduced that the cell viability increases when the wettability increases. This effect is more pronounced when the titania content is higher. Finally, a comet test was applied as complementary biocompatibility test to detect any changes in fibroblast cell DNA. The results showed that the DNA damage is intimately related to the TiO 2 content. Genotoxicity was mainly attributed to ceramic composites containing 10 wt.% TiO 2 . Our research revealed that the newly developed high performance alumina-zirconia-titania ceramic composites contain less than 10 wt.% TiO 2 , and display promising surface properties, making them suitable for dental implantology applications. of alumina is also its main deficiency. Indeed, the high rate of fractures in various alumina-based implants was reported on by clinical evaluations [6]. Zirconia (ZrO 2 ) ceramics were then introduced in implantology due to their resistance to fracture, their toughness (which is higher than the alumina), and their excellent biocompatibility [7]. However, zirconia bioceramics have a low resistance to ageing due to their transformation from the tetragonal phase (t) to the monoclinic phase (m) in the human body. This transformation is accompanied by an expansion of about 4% to 5% in volume. This volumetric expansion creates compressive stresses resulting in the drop of mechanical performances [8].Up to now, great efforts have been made to produce a new class of dental biomaterials with high mechanical performances. The combination of the high stiffness of alumina and the excellent toughness of zirconia could be an effective strategy [9]. Nevertheless, the previous works on alumina-zirconia ceramic composites revealed complex and high cost manufacturing processes such as hot-press sintering [10].Furthermore, several additives, such as TiO 2 , have been used in order to improve the sintering and enhance the ceramic performances of composites [11]. TiO 2 has also showed excellent bioactivity, promoting the attachment of implants with living bone tissues in a short time [12]. Al 2 O 3 -ZrO 2 -TiO 2 ceramic composites for dental application have recently been developed [13][14][15]...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.